Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells

Bone metastases represent common long term complications of patients with breast cancer. Zoledronic acid, an amino-bisphosphonate and mevalonate pathway inhibitor, is an established agent for the treatment of bone metastases. Direct antitumor effects of zoledronic acid have been proposed in breast c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilke, Maria, Göbel, Andy, Rauner, Martina, Benad-Mehner, Peggy, Schütze, Norbert, Füssel, Susanne, Hadji, Peyman, Hofbauer, Lorenz C., Rachner, Tilman D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723419/
https://www.ncbi.nlm.nih.gov/pubmed/26909293
http://dx.doi.org/10.1016/j.jbo.2014.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723419/
https://www.ncbi.nlm.nih.gov/pubmed/26909293
http://dx.doi.org/10.1016/j.jbo.2014.02.001

Ejemplares similares